CTGov Compliance My Organizations

Compliance Rate

Compliance Rate 0%

Compliant submissions 0

Incompliant submissions 0

Total trials 0

My Organizations' Clinical Trials

Showing 100 of 110 entries

View as:

The Registry Study of Genetic Alterations of Esophageal Cancer in Taiwan

Phase: N/A Priority: Normal

NCT ID: NCT04996095 Org: User:

Start: 10/01/21 End: 12/31/29 Due: 12/31/30

SLOG Vs MFOLFIRINOX As the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03443492 Org: User:

Start: 03/26/18 End: 11/30/19 Due: 11/30/20

Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma.

Phase: N/A Priority: Normal

NCT ID: NCT04688151 Org: User:

Start: 02/22/21 End: 12/31/25 Due: 12/31/26

Biomarkers Study in Pancreatic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01666184 Org: User:

Start: 09/30/12 End: 12/31/17 Due: 12/31/18

A Phase II Study of Locally Advanced Pancreatic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT01867892 Org: User:

Start: 06/30/13 End: 05/31/19 Due: 05/31/20

Sorafenib Plus S-1 in Advanced Solid Tumors

Phase: N/A Priority: Normal

NCT ID: NCT01128998 Org: User:

Start: 11/30/09 End: 10/31/15 Due: 10/31/16

A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine

Phase: N/A Priority: Normal

NCT ID: NCT01268787 Org: User:

Start: 12/31/10 End: 09/30/12 Due: 09/30/13

SAPPHIRe III in Taiwan-Progression Evaluation and Cardiovascular Outcomes of Hypertensive Families

Phase: N/A Priority: Normal

NCT ID: NCT00631956 Org: User:

Start: 10/31/06 End: 12/31/16 Due: 12/31/17

The Study of Metastatic Pancreatic Adenocarcinoma

Phase: N/A Priority: Normal

NCT ID: NCT01415713 Org: User:

Start: 03/31/12 End: 04/30/16 Due: 04/30/17

Vegetable Signature From Human Metabolomics Responses

Phase: N/A Priority: Normal

NCT ID: NCT03483558 Org: User:

Start: 06/11/11 End: 05/28/15 Due: 05/28/16

Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA

Phase: N/A Priority: Normal

NCT ID: NCT03544099 Org: User:

Start: 05/07/19 End: 12/31/21 Due: 12/31/22

Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients

Phase: N/A Priority: Normal

NCT ID: NCT02457273 Org: User:

Start: 07/04/15 End: 12/01/18 Due: 12/01/19

A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer

Phase: N/A Priority: Normal

NCT ID: NCT03246854 Org: User:

Start: 07/18/17 End: 08/04/18 Due: 08/04/19

Molecular Genetic Study of Avascular Necrosis of the Femoral Head

Phase: N/A Priority: Normal

NCT ID: NCT00260897 Org: User:

Start: 05/31/03 End: 04/30/08 Due: 04/30/09

A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma

Phase: N/A Priority: Normal

NCT ID: NCT05622409 Org: User:

Start: 12/29/22 End: 12/31/30 Due: 12/31/31

Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma

Phase: N/A Priority: Normal

NCT ID: NCT00201422 Org: User:

Start: 06/30/96 End: 01/31/04 Due: 01/31/05

A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients

Phase: N/A Priority: Normal

NCT ID: NCT01389583 Org: User:

Start: 10/31/11 End: 10/31/19 Due: 10/31/20

A Prospective Study on Diabetes Management Through an Integrated Delivery System

Phase: N/A Priority: Normal

NCT ID: NCT00288678 Org: User:

Start: 07/31/03 End: 12/31/07 Due: 12/31/08

A Phase III Study of Pancreatic Cancer

Phase: N/A Priority: Normal

NCT ID: NCT00994721 Org: User:

Start: 02/28/09 End: 01/31/16 Due: 01/31/17

Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients

Phase: N/A Priority: Normal

NCT ID: NCT01744587 Org: User:

Start: 04/30/13 End: 12/31/20 Due: 12/31/21

A Taiwan Isoflavone Multicenter Study (TIMS)

Phase: N/A Priority: Normal

NCT ID: NCT00262184 Org: User:

Start: 12/31/04 End: 12/31/07 Due: 12/31/08

Methadone Maintenance Treatment Outcome Study in Taiwan

Phase: N/A Priority: Normal

NCT ID: NCT01093248 Org: User:

Start: 07/31/09 End: 12/31/12 Due: 12/31/13

Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers

Phase: N/A Priority: Normal

NCT ID: NCT03162510 Org: User:

Start: 06/26/18 End: 01/31/22 Due: 01/31/23

A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma

Phase: N/A Priority: Normal

NCT ID: NCT00455091 Org: User:

Start: 05/31/07 End: 04/30/18 Due: 04/30/19

Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome

Phase: N/A Priority: Normal

NCT ID: NCT00327132 Org: User:

Start: 07/31/06 End: 12/31/15 Due: 12/31/16

Title	NCT ID	Organization	User	Status	Start Date	End Date	Reporting Due Date	Last Checked	User Role	Org Created
The Registry Study of Genetic Alterations of Esophageal Cancer in Taiwan	NCT04996095	National Health Research Institutes, Taiwan	user2@example.com	None	2021-10-01	2029-12-31	2030-12-31	-	-	2025-07-14
SLOG Vs MFOLFIRINOX As the First-line Treatment in Locally Advanced Uncresectable or Metastatic Pancreatic Cancer	NCT03443492	National Health Research Institutes, Taiwan	user2@example.com	None	2018-03-26	2019-11-30	2020-11-30	-	-	2025-07-14
Rituximab, Acalabrutinib, and Durvalumab (RAD) in Primary CNS Lymphoma.	NCT04688151	National Health Research Institutes, Taiwan	user2@example.com	None	2021-02-22	2025-12-31	2026-12-31	-	-	2025-07-14
Biomarkers Study in Pancreatic Cancer	NCT01666184	National Health Research Institutes, Taiwan	user2@example.com	None	2012-09-30	2017-12-31	2018-12-31	-	-	2025-07-14
A Phase II Study of Locally Advanced Pancreatic Cancer	NCT01867892	National Health Research Institutes, Taiwan	user2@example.com	None	2013-06-30	2019-05-31	2020-05-31	-	-	2025-07-14
Sorafenib Plus S-1 in Advanced Solid Tumors	NCT01128998	National Health Research Institutes, Taiwan	user2@example.com	None	2009-11-30	2015-10-31	2016-10-31	-	-	2025-07-14
A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine	NCT01268787	National Health Research Institutes, Taiwan	user2@example.com	None	2010-12-31	2012-09-30	2013-09-30	-	-	2025-07-14
SAPPHIRe III in Taiwan-Progression Evaluation and Cardiovascular Outcomes of Hypertensive Families	NCT00631956	National Health Research Institutes, Taiwan	user2@example.com	None	2006-10-31	2016-12-31	2017-12-31	-	-	2025-07-14
The Study of Metastatic Pancreatic Adenocarcinoma	NCT01415713	National Health Research Institutes, Taiwan	user2@example.com	None	2012-03-31	2016-04-30	2017-04-30	-	-	2025-07-14
Vegetable Signature From Human Metabolomics Responses	NCT03483558	National Health Research Institutes, Taiwan	user2@example.com	None	2011-06-11	2015-05-28	2016-05-28	-	-	2025-07-14
Pembrolizumab for Nasopharyngeal Carcinoma Patients With Detectable Plasma Epstein-Barr Virus DNA	NCT03544099	National Health Research Institutes, Taiwan	user2@example.com	None	2019-05-07	2021-12-31	2022-12-31	-	-	2025-07-14
Phase II Study to Evaluate the Efficacy and Safety of TLC388 for Differentiated Neuroendocrine Carcinomas Patients	NCT02457273	National Health Research Institutes, Taiwan	user2@example.com	None	2015-07-04	2018-12-01	2019-12-01	-	-	2025-07-14
A Study of DBPR112 in Patients With Head and Neck Cancer and EGFR Mutated Lung Cancer	NCT03246854	National Health Research Institutes, Taiwan	user2@example.com	None	2017-07-18	2018-08-04	2019-08-04	-	-	2025-07-14
Molecular Genetic Study of Avascular Necrosis of the Femoral Head	NCT00260897	National Health Research Institutes, Taiwan	user2@example.com	None	2003-05-31	2008-04-30	2009-04-30	-	-	2025-07-14
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma	NCT05622409	National Health Research Institutes, Taiwan	user2@example.com	None	2022-12-29	2030-12-31	2031-12-31	-	-	2025-07-14
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma	NCT00201422	National Health Research Institutes, Taiwan	user2@example.com	None	1996-06-30	2004-01-31	2005-01-31	-	-	2025-07-14
A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients	NCT01389583	National Health Research Institutes, Taiwan	user2@example.com	None	2011-10-31	2019-10-31	2020-10-31	-	-	2025-07-14
A Prospective Study on Diabetes Management Through an Integrated Delivery System	NCT00288678	National Health Research Institutes, Taiwan	user2@example.com	None	2003-07-31	2007-12-31	2008-12-31	-	-	2025-07-14
A Phase III Study of Pancreatic Cancer	NCT00994721	National Health Research Institutes, Taiwan	user2@example.com	None	2009-02-28	2016-01-31	2017-01-31	-	-	2025-07-14
Epstein-Barr Virus Reactivation and the Effect of EGCG on Virus Reactivation in Remission Patients	NCT01744587	National Health Research Institutes, Taiwan	user2@example.com	None	2013-04-30	2020-12-31	2021-12-31	-	-	2025-07-14
A Taiwan Isoflavone Multicenter Study (TIMS)	NCT00262184	National Health Research Institutes, Taiwan	user2@example.com	None	2004-12-31	2007-12-31	2008-12-31	-	-	2025-07-14
Methadone Maintenance Treatment Outcome Study in Taiwan	NCT01093248	National Health Research Institutes, Taiwan	user2@example.com	None	2009-07-31	2012-12-31	2013-12-31	-	-	2025-07-14
Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers	NCT03162510	National Health Research Institutes, Taiwan	user2@example.com	None	2018-06-26	2022-01-31	2023-01-31	-	-	2025-07-14
A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma	NCT00455091	National Health Research Institutes, Taiwan	user2@example.com	None	2007-05-31	2018-04-30	2019-04-30	-	-	2025-07-14
Prospective Study of First-line Antibiotic Therapy for Early-stage Gastric MALT Lymphoma for Treatment Outcome	NCT00327132	National Health Research Institutes, Taiwan	user2@example.com	None	2006-07-31	2015-12-31	2016-12-31	-	-	2025-07-14

Compliance Rate

My Organizations' Clinical Trials

Appearance